fluconazole has been researched along with fluphenazine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Rahkhoodaee, F; Raymond, M; Tsao, S | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bonchi, C; Botta, M; Bugli, F; Casian, A; D'Arezzo, S; De Luca, F; Deodato, D; Docquier, JD; Maccari, G; Martini, R; Posteraro, B; Sanfilippo, S; Sanglard, D; Sanguinetti, M; Vandeputte, P; Visca, P | 1 |
| Guo, Q; Hu, T; Lu, Y; Mo, L; Peng, X; Ren, B; Xu, X; Zhou, X; Zhou, Z | 1 |
| Beattie, SR; Conway, T; Guin, S; Krysan, DJ; Meyers, MJ; Miron-Ocampo, A; Moye-Rowley, WS | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 review(s) available for fluconazole and fluphenazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for fluconazole and fluphenazine
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines | 2009 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Macrocyclic Compounds; Mice; Microbial Sensitivity Tests; Microscopy, Fluorescence; Yeasts | 2016 |
Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Topics: Amphotericin B; Animal Structures; Animals; Antifungal Agents; Antipsychotic Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Fluconazole; Fluphenazine; Gene Expression Profiling; Gene Expression Regulation, Fungal; Mice; Treatment Outcome | 2019 |
CWHM-974 is a fluphenazine derivative with improved antifungal activity against
Topics: Antifungal Agents; Candida; Candida albicans; Drug Resistance, Fungal; Drug Resistance, Multiple; Fluconazole; Fluphenazine; Fungal Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests | 2023 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |